(PGNX:Consolidated Issue Listed on NASDAQ Global Select )
Mark R. Baker J.D.
Chief Executive Officer, Director and Member of Science & Strategy Committee, Progenics Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 25 board members in 3 different organizations across 2 different industries.|
See Board Relationships
As of Fiscal Year 2013
Mr. Mark R. Baker, J.D. has been the Chief Executive Officer of Progenics Pharmaceuticals, Inc. since March 2011 and served as its President from September 2009 to March 3, 2011. Mr. Baker served as a Secretary and General Counsel of Progenics Pharmaceuticals, Inc. since June 20, 2005 and served as its Executive Vice President-Corporate from 2008 to 2009. He served as Senior Vice President of Progenics Pharmaceuticals Inc., since June 20, 2005. He served as Chief Legal ...
777 Old Saw Mill River RoadPhone: 914-789-2800
Tarrytown, New York 10591
Board Members Memberships*
Chairman of the Board, Member of Executive Committee and Member of Compensation Committee
Non-Executive Chairman of the Board, Chief Legal Officer of Contigroup and Senior Vice President of Contigroup
Chief Executive Officer, Director and Member of Science & Strategy Committee
School Of Law, Columbia University
Columbia Business School
|James M. Gower||Chairman, Chief Executive Officer and Member of Finance Committee|
Rigel Pharmaceuticals, Inc.
|Steven W. King||Chief Executive Officer, President, Director, Chief Executive Officer of Avid Bioservices Inc and President of Avid Bioservices Inc|
Peregrine Pharmaceuticals, Inc.
|Eddie Gray||Chief Executive Officer and Director|
Dynavax Technologies Corporation
|Jonathan J. Lewis M.D., Ph.D.||Chief Executive Officer and Director|
ZIOPHARM Oncology, Inc.
|William D. Clark||Chief Executive Officer, President and Director|
Genocea Biosciences, Inc.
|$334.3K||Compensation as of Fiscal Year 2013.|